Not exact matches
On its own, this immune response had no immediate effect in the fight
against the utilized breast tumors, but in combination with the ADC it proved itself effective in
attacking cancer cells in mice, resulting in the complete cure of the majority of mice receiving the combination therapy.
Immunotherapy is an emerging field in the global fight
against cancer, even though scientists and clinicians have been working for decades to find ways to help the body's immune system detect and
attack cancerous
cells.
Whether investigating fat
cells, immunotherapy or use of the CRISPR - Cas 9 gene - editing tool, which a federal panel recently approved for a select number of patients suffering from three types of
cancers, including multiple myeloma, approaches beyond
attacking cancer cells are needed in the fight
against many
cancers.
One promising strategy in the fight
against cancer is to use the body's own immune system to remove tumor
cells, but due to a phenomenon called immune tolerance, the immune system has a difficult time identifying which
cells to
attack.
Immunity is key to long - term responses Knowing that the immune system is capable of recognizing distinctive features of
cancer cells and launching a T
cell attack against those tumor antigens, and that checkpoint blockade removes a roadblock to that
attack, it's logical that these drugs should work
against many tumor types.
Cancer vaccines are designed to stimulate an immune response against tumor - specific or tumor - associated antigens, encouraging the immune system to attack cancer cells bearing these ant
Cancer vaccines are designed to stimulate an immune response
against tumor - specific or tumor - associated antigens, encouraging the immune system to
attack cancer cells bearing these ant
cancer cells bearing these antigens.
Another approach, still early in clinical development, uses antibodies to vaccinate patients
against their own tumours, pushing their immune system to
attack the
cancer cells.
Therapeutic vaccines are designed to elicit an immune response
against tumor - specific or tumor - associated antigens, encouraging the immune system to
attack cancer cells bearing these antigens.
Therapeutic
cancer vaccines are designed to elicit an immune response
against tumor - specific or tumor - associated antigens, encouraging the immune system to
attack cancer cells bearing these antigens.
He is the principal investigator of an NCI - funded, multi-million-dollar Specialized Program of Research Excellence (SPORE) in ovarian
cancer, and he is the principal investigator of a multi-million-dollar grant from the New York State Stem
Cell Science program (NYSTEM) to pioneer a novel strategy of reprogramming human mature T
cells and hematopoietic stem
cells for generating sustained
attack against ovarian
cancer in patients.
They can
attack cancer cells directly, or they can be used to trigger an immune response
against the tumor (so - called
cancer immunotherapy).
A novel approach to
cancer immunotherapy — strategies designed to induce the immune system to
attack cancer cells — may provide a new and cost - effective weapon
against some of the most deadly tumors, including ovarian
cancer and mesothelioma.
Tactiva's lead platform is a unique approach to adoptive
cell transfer (ACT), a form of immunotherapy in which a patient's own immune
cells are drawn from blood, genetically engineered, multiplied and injected back into the patient in order to launch a powerful
attack against cancer.